Skip to content
Screener

Cue Biopharma CUE Q4 2025 Annual earnings

Reported March 16, 2026 · Before market open

Revenue$21.9MBeat by $20.9M
EPS$0.01Beat by $0.10
Revenue estimate$1.0M
EPS estimate-$0.09

Next report

Nov 11, 2026 (In 1 week)
Revenue estimate$1.0M
EPS estimate-$2.24

FAQ

When did Cue Biopharma report Q4 2025 earnings?
Cue Biopharma (CUE) reported Q4 2025 earnings on March 16, 2026 before market open.
What were Cue Biopharma's Q4 2025 revenue and EPS?
Cue Biopharma reported revenue of $21.9M and eps of $0.01 for Q4 2025.
Did Cue Biopharma beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.0M by $20.9M. EPS beat the consensus estimate of $-0.09 by $0.10.
How did Cue Biopharma's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1292.3% from $1.6M a year earlier.
Where can I find Cue Biopharma's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-108292) and the 10-K periodic report (0001193125-26-108287) directly on SEC EDGAR. The filing index links above go to sec.gov.